June 03, 2019
GUELPH and KITCHENER, June 3, 2019—BDC Capital’s Growth and Transition Capital division provided a $2-million non-dilutive facility to fund research and development at Guelph-based Nutrasource Pharmaceutical and Nutraceutical Services, a global contract research organization providing regulatory, R&D, clinical trials, and analytical testing solutions for the health product and food sectors. Founded in 2002, Nutrasource helps companies gain market access by developing regulatory strategies, validating product claims, generating clinical research, and providing market guidance at all stages of the supply chain. The company has notably developed third-party certification programs for fish oils, probiotics and non-GMO products, along with a unique concept-to-claim platform for global clinical and regulatory programs.